Joseph Baroldi, EVP, Chief Business Officer at IONIS PHARMACEUTICALS INC (IONS), sold 32,800 shares at $59.09 ($1.9M) on 2025-09-03, disclosed to the SEC on 2025-09-04.
Scheduled sale ($1.9M) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.09 | 30,000 | $1.8M | 91.1% |
| 2 | $62.01 | 2,800 | $174K | 8.9% |
| Total | $59.34 avg | 32,800 | $1.9M | 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $419K | — | Filing → |
| IONS | SELL | 2026-03-05 | $531K | — | Filing → |
| IONS | SELL | 2026-02-02 | $439K | — | Filing → |